» Articles » PMID: 38385745

Critical and Distinct Roles of Cell Type-specific NF-κB2 in Lung Cancer

Overview
Journal JCI Insight
Date 2024 Feb 22
PMID 38385745
Authors
Affiliations
Soon will be listed here.
Abstract

Different from the well-studied canonical NF-κB member RelA, the role of the noncanonical NF-κB member NF-κB2 in solid tumors, and lung cancer in particular, is poorly understood. Here we report that in contrast to the tumor-promoting role of RelA, NF-κB2 intrinsic to lung epithelial and tumor cells had no marked effect on lung tumorigenesis and progression. On the other hand, NF-κB2 limited dendritic cell number and activation in the lung but protected lung macrophages and drove them to promote lung cancer through controlling activation of noncanonical and canonical NF-κB, respectively. NF-κB2 was also required for B cell maintenance and T cell activation. The antitumor activity of lymphocyte NF-κB2 was dominated by the protumor function of myeloid NF-κB2; thus, NF-κB2 has an overall tumor-promoting activity. These studies reveal a cell type-dependent role for NF-κB2 in lung cancer and help understand the complexity of NF-κB action and lung cancer pathogenesis for better design of NF-κB-targeted therapy against this deadliest cancer.

Citing Articles

NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.

Song X, Qu Z PLoS One. 2024; 19(5):e0303138.

PMID: 38722890 PMC: 11081228. DOI: 10.1371/journal.pone.0303138.


NF-κB RelA is a cell-intrinsic metabolic checkpoint restricting glycolysis.

Li L, Han L, Qu Z Cell Biosci. 2024; 14(1):11.

PMID: 38245770 PMC: 10799406. DOI: 10.1186/s13578-024-01196-7.

References
1.
Basseres D, Ebbs A, Levantini E, Baldwin A . Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res. 2010; 70(9):3537-46. PMC: 2862109. DOI: 10.1158/0008-5472.CAN-09-4290. View

2.
Rayet B, Gelinas C . Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999; 18(49):6938-47. DOI: 10.1038/sj.onc.1203221. View

3.
Gilmore T . NF-κB and Human Cancer: What Have We Learned over the Past 35 Years?. Biomedicines. 2021; 9(8). PMC: 8389606. DOI: 10.3390/biomedicines9080889. View

4.
Sun F, Qu Z, Xiao Y, Zhou J, Burns T, Stabile L . NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function. Oncogene. 2015; 35(18):2299-310. PMC: 4548811. DOI: 10.1038/onc.2015.299. View

5.
Qing G, Qu Z, Xiao G . Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters. Proc Natl Acad Sci U S A. 2007; 104(13):5324-9. PMC: 1838492. DOI: 10.1073/pnas.0609914104. View